CervoMed Inc. 8-K

What Happened
CervoMed Inc. (CRVO) filed an 8-K on May 18, 2026 to announce quarterly financial results via a press release (attached as Exhibit 99.1). The filing states the results cover the three months ended December 31, 2026 and includes a disclosure about the company's cash position and near-term liquidity.

Key Details

• Press release dated May 18, 2026 announcing financial results for the three months ended December 31, 2026 (Exhibit 99.1).
• Filing states the company had ".9 million" in cash, cash equivalents and marketable securities as of March 31, 2026.
• Based on the company’s operating plan, that cash position is expected to fund planned operating and capital expenses into September 2026.
• The disclosures in Items 2.02 and 7.01 are furnished (not “filed”) and therefore are not subject to the liability provisions of Section 18 of the Exchange Act.

Why It Matters
Investors get the company’s most recent quarterly results and an explicit update on liquidity and runway. The stated cash balance and the September 2026 funding horizon highlight the company’s near-term financing needs — if expenses or plans change, CervoMed may need to raise additional capital before that date. The “furnished, not filed” status is a legal detail that limits certain liabilities for these disclosures.